235 related articles for article (PubMed ID: 6977173)
1. Anti-DNA antibodies by the Farr and the Crithidia luciliae assays and the clinical status of systemic lupus erythematosus.
Lavalle C; Núñez A; Muñoz E
Rev Invest Clin; 1981; 33(4):349-54. PubMed ID: 6977173
[No Abstract] [Full Text] [Related]
2. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique.
Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689
[TBL] [Abstract][Full Text] [Related]
3. The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus.
Burdash NM; Teti G; Papadopoulos V
Ann Clin Lab Sci; 1983; 13(1):49-54. PubMed ID: 6340594
[TBL] [Abstract][Full Text] [Related]
4. Complement fixing antibodies to DS-DNA in systemic lupus erythematosus: a study using the immunofluorescent Crithidia luciliae method.
Beaulieu A; Quismorio FP; kitridou RC; Friou GJ
J Rheumatol; 1979; 6(4):389-96. PubMed ID: 392093
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus and the crithidia luciliae immunofluorescent test. A comparative study with an adapted Farr radioimmunoassay.
Whitehouse IJ; Fehr K; Wagenhäuser FJ
Z Rheumatol; 1983; 42(1):28-35. PubMed ID: 6342296
[TBL] [Abstract][Full Text] [Related]
6. The significance of discrepant Farr and Crithidia luciliae tests.
McGuigan L; Edmonds J; Wellings G; Jones M
J Rheumatol; 1984 Apr; 11(2):172-4. PubMed ID: 6610050
[TBL] [Abstract][Full Text] [Related]
7. [Antibodies against native (double-strand) deoxyribonucleic acid and complement fixing antibodies in generalized lupus erythematosus with affected kidneys].
Dostál C; Hána I; Bardfeld R; Stejskal J; Matl I; Zvárová J
Vnitr Lek; 1984 May; 30(5):417-25. PubMed ID: 6331681
[No Abstract] [Full Text] [Related]
8. [Anti-DNA determination using Crithidia luciliae. Specificity and clinical usefulness in systemic lupus erythematosus].
Pena Sagredo JL; Orte Martinez FJ; Sanchez Andrada S; Sampedro Alvarez J; Novo Fernandez MJ; Rodriguez Valverde V
Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):345-50. PubMed ID: 7048503
[TBL] [Abstract][Full Text] [Related]
9. [Systemic lupus erythematosus and anti-native-DNA antibodies measured using Crithidia luciliae].
Maradona Hidalgo JA; Alvarez Alvarez C; Asensi Alvarez V; Diéguez Junquera MA
Med Clin (Barc); 1985 Mar; 84(10):416-7. PubMed ID: 3872979
[No Abstract] [Full Text] [Related]
10. [Specificity of antibodies against native DNA using Crithidia luciliae. Clinical and analytical features of patients with and without antibodies against native DNA in systemic lupus erythematosus].
Peña Sagredo JL; Riestra Noriega JL; Sánchez Andrada S; Luceño Vázquez A; Rodríguez Valverde V
Med Clin (Barc); 1984 Jun; 83(3):94-6. PubMed ID: 6384685
[No Abstract] [Full Text] [Related]
11. The Crithidia luciliae kinetoplast immunofluorescence test in systemic lupus erythematosus.
Slater NG; Cameron JS; Lessof MH
Clin Exp Immunol; 1976 Sep; 25(3):480-6. PubMed ID: 786521
[TBL] [Abstract][Full Text] [Related]
12. Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus.
Dixon JA; Mulhern LM; Whiteside TL; Luksick J
J Rheumatol; 1980; 7(4):544-6. PubMed ID: 6999152
[TBL] [Abstract][Full Text] [Related]
13. [Levels of anti-nDNA using immunofluorescence on Crithidia luciliae. II. Prognostic value of complement-fixing anti-nDNA. Longitudinal study of 16 lupus disorders].
Meyer O; Borda-Iriarte O; Cyna J; Haïm T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1984 May; 51(5):243-9. PubMed ID: 6377460
[TBL] [Abstract][Full Text] [Related]
14. [The clinical significance of antibodies against double stranded DNA. Comparative study, using the Farr assay and the crithidia luciliae immunofluorescent test (author's transl)].
Genth E; Hagemann W; Sennekamp J; Hartl W
Immun Infekt; 1977 Dec; 5(6):241-51. PubMed ID: 338473
[No Abstract] [Full Text] [Related]
15. [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus].
Pigrau A; Martínez-Vázquez JM; Bacardí R; Ocanña I; Pahissa A
Med Clin (Barc); 1984 Dec; 83(19):787-91. PubMed ID: 6335542
[No Abstract] [Full Text] [Related]
16. [Kinetoplast of Crithidia luciliae as a substrate for demonstrating antibodies against native DNA in systemic lupus erythematosus].
Herrera-Esparza R; Escobar-Luján M; Avalos-Díaz E; Guzmán-Enríquez L
Bol Med Hosp Infant Mex; 1983 Apr; 40(4):208-11. PubMed ID: 6347221
[No Abstract] [Full Text] [Related]
17. Detection of anti-DNA antibodies: a comparison between two Farr assays, Crithidia luciliae and a human chromosomal substrate assay.
Tipping PG; Buchanan RR; Riglar AG; Dimech WJ; Littlejohn GO; Holdsworth SR
Br J Rheumatol; 1988 Jun; 27(3):206-10. PubMed ID: 3288291
[TBL] [Abstract][Full Text] [Related]
18. Membranous glomerulopathy in systemic lupus erythematosus.
Gonzalez-Dettoni H; Tron F
Adv Nephrol Necker Hosp; 1985; 14():347-64. PubMed ID: 3919538
[No Abstract] [Full Text] [Related]
19. Clinical usefulness of the Crithida luciliae test for antibodies to native DNA.
Whiteside TL; Dixon JA
Am J Clin Pathol; 1979 Nov; 72(5):829-35. PubMed ID: 389032
[TBL] [Abstract][Full Text] [Related]
20. [Immunofluorescence on Crithidia luciliae in the detection of anti-native DNA antibodies (author's transl)].
André C; Villeminot S; Bourhala S
Nouv Presse Med; 1982 Apr; 11(15):1127-30. PubMed ID: 7043393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
